Science Exchange Symposium - Early Stage Drug Development

Wednesday, October 9 2013
5:00 pm – 7:15 pm

This event was posted by Consulate General of Canada

Event Inquiries

David Leroux-Petersen at 514 349-9683 or ScienceExchange@algopharm.com

Location: Boston Marriott Cambridge - Kendall Square

Presentations from industry experts on early phase drug development covering both clinical and bioanalytical perspectives.

Topics will include:

  • Defying Circular Logic in Venture Capital: Raising Risk Capital for Early Stage Assets in a World that Values Clinical Data
    Dr. Corey McCann, Principal, MPM Capital
  • Key Considerations for Developing Efficient First-in-Human (FIH) Clinical Trials: A Case study Analysis
    Dr. Marc Lefebvre, Vice-President, Scientific & Regulatory Affairs, Algorithme Pharma
  • Technical and Operational Challenges of Designing Clinical Studies in Ultra Rare Disease Drug Development
    Dr. Mike Collins, Vice-President, Global Clinical Operations,
    Alexion Pharmaceuticals
  • Overcoming Bioanalytical Challenges During Clinical Sample Collections
    Dr. Fabio Garofolo, Vice-President, Bioanalytical Services,
    Algorithme Pharma

    This is a complimentary symposium, sponsored by Algorithme Pharma. 

Share MassBio

 

EvaluatePharma

MassBio